The Latest Breaking News from ETF

Defiance ETFs launched its newest leveraged product on Sept. 3, the Defiance Daily Target 2X Short LLY ETF (NASDAQ:LLYZ). The new fund is designed for traders seeking to short pharmaceutical giant Eli Lilly and Co (NYSE:LLY).

For decades, ETFs have been the workhorse of contemporary investing. They’re accessible to trade, inexpensive, and track everything from the SP 500 to specialized themes such as artificial intelligence and clean energy. But investor expectations continue to shift. Now, advisers are exploring portfolios that suit the individual goals, values, and…

A drop in the 10-year U.S. Treasury yield below the key 4% level could ignite a significant rally in technology and other growth stocks, according to prominent investor Gary Black.

The artificial intelligence revolution is undeniable, with AI mentions in SP 500 earnings calls skyrocketing to an all-time high of 287 in the second quarter of 2025.

Exchange-traded funds (ETFs) have exploded in popularity over the past two decades. Many retirees and investors moved money from mutual funds to ETFs for lower...

Digital asset investment products rebounded last week, recording $2.48 billion in inflows, lifting total inflows for August to $4.37 billion and year-to-date inflows to $35.5 billion, according to a CoinShares report on Monday.

Dogecoin (CRYPTO: DOGE) has surged above 23 cents as anticipation builds around the launch of the first Dogecoin ETF this week.

While investor enthusiasm for artificial intelligence (AI) continues to drive markets, technology analyst Beth Kindig has issued a specific warning: a bubble is forming, but it’s concentrated primarily in the AI software sector.

Billionaire entrepreneur Mark Cuban, in a series of posts on the social media platform X early Monday morning, launched a scathing critique of the U.S. prescription drug industry, accusing large wholesalers and Pharmacy Benefit Managers (PBMs) of creating a “stranglehold” on pricing through opaque, anti-competitive practices.